前立腺がん抗原3検査の世界市場インサイト、2030年までの予測Global Prostate Cancer Antigen 3 Test Market Insights, Forecast to 2030 前立腺癌抗原3検査の世界市場規模は、2023年の5,169万米ドルから、2024〜2030年のCAGR 9.09%で、2030年には9,364万米ドルに達すると予測される。 米国とカナダの前立腺癌抗原3検査の市場規模は、2023年の1,910万... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー前立腺癌抗原3検査の世界市場規模は、2023年の5,169万米ドルから、2024〜2030年のCAGR 9.09%で、2030年には9,364万米ドルに達すると予測される。米国とカナダの前立腺癌抗原3検査の市場規模は、2023年の1,910万ドルから、2024年から2030年の予測期間中にCAGR 8.96%で、2030年には3,431万ドルに達すると推定される。 前立腺癌抗原3検査の中国市場は、2023年に750万ドルから増加し、2024年から2030年の予測期間中に11.03%のCAGRで、2030年までに1534万ドルに達すると推定される。 前立腺癌抗原3検査の欧州市場は、2024年から2030年の予測期間中に8.20%のCAGRで、2023年に1559万ドルから増加し、2030年までに2669万ドルに達すると推定される。 前立腺癌抗原3検査の世界的な主要企業は、Hologic社、サーモフィッシャーサイエンティフィック社、MDxHealth社、Exosome Diagnostics GmbH社、Creative Diagnostics社、Lytech社、YUBO社、MicroDiag Biomedicine社などである。2023年、世界の上位5社の売上高シェアは約82.81%であった。 レポートの内容 前立腺癌抗原3検査の世界市場規模を概観します。2019年~2023年の過去の市場収益データ、2024年の推定値、2030年までのCAGR予測による世界市場動向の分析。 前立腺癌抗原3検査の主要生産者を調査し、主要地域・国の収益も掲載しています。前立腺癌抗原3検査の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点のハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。 本レポートでは、2019年から2024年までのデータで、前立腺がん抗原3検査の収益、市場シェア、主要企業の業界ランキングに焦点を当てています。世界の前立腺癌抗原3検査市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。 本レポートでは、2019年から2030年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。前立腺癌抗原3検査の収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。 Hologic社、Thermo Fisher Scientific社、MDxHealth社、Exosome Diagnostics GmbH社、Creative Diagnostics社、Lytech社、YUBO社、MicroDiag Biomedicine社など、世界の主要企業の詳細な企業プロフィール。 市場セグメンテーション 企業別 ホロジック サーモフィッシャーサイエンティフィック MDxHealth エクソソーム・ダイアグノスティックス クリエイティブ・ダイアグノスティックス ライテック ユーボ マイクロダイアグバイオメディシン タイプ別セグメント RT-PCR検査 ELISA検査 アプリケーション別 病院 診断センター その他 地域別 北米 米国 カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア ヨーロッパ ドイツ フランス 英国 イタリア スペイン その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ 中東 アフリカ 各章の概要 第1章: レポートのスコープ、各市場セグメント(製品タイプ、用途など)の市場規模、将来の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と短期・中期・長期的な発展可能性についてハイレベルな見解を提供する。 第2章 前立腺癌抗原3検査の世界および地域レベルでの収益各地域と主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介します。 第3章:前立腺癌抗原3検査企業鈥の競争環境、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。 第4章:各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展の可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけるのに役立つ。 第5章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。 第6章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の収益。 第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別収益。 第8章:中国:タイプ別、用途別、セグメント別収益。 第9章:アジア(中国を除く):タイプ別、用途別、地域別、各セグメントの収益。 第10章:中東、アフリカ、ラテンアメリカ:タイプ別、用途別、国別、セグメント別収益。 第11章:主要企業のプロファイルを提供し、製品の説明や仕様、前立腺癌抗原3検査の収益、売上総利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。 第12章:アナリストの視点/結論 目次1 Report Overview 11.1 Study Scope 1 1.2 Market Analysis by Type 1 1.2.1 Global Prostate Cancer Antigen 3 Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030 1 1.2.2 RT-PCR 2 1.2.3 ELISA Test 3 1.3 Market by Application 3 1.3.1 Global Prostate Cancer Antigen 3 Test Market Share by Application: 2019 VS 2023 VS 2030 4 1.3.2 Hospital 5 1.3.3 Diagnosis Center 5 1.3.4 Others 5 1.4 Assumptions and Limitations 5 1.5 Study Objectives 6 1.6 Years Considered 7 2 Global Growth Trends 8 2.1 Global Prostate Cancer Antigen 3 Test Market Perspective (2019-2030) 8 2.2 Global Prostate Cancer Antigen 3 Test Growth Trends by Region 9 2.2.1 Global Prostate Cancer Antigen 3 Test Market Size by Region: 2019 VS 2023 VS 2030 10 2.2.2 Prostate Cancer Antigen 3 Test Historic Market Size by Region (2019-2024) 11 2.2.3 Prostate Cancer Antigen 3 Test Forecasted Market Size by Region (2025-2030) 12 2.3 Prostate Cancer Antigen 3 Test Market Dynamics 13 2.3.1 Prostate Cancer Antigen 3 Test Industry Trends 13 2.3.2 Prostate Cancer Antigen 3 Test Market Drivers 13 2.3.3 Prostate Cancer Antigen 3 Test Market Challenges 14 2.3.4 Prostate Cancer Antigen 3 Test Market Restraints 14 3 Competition Landscape by Key Players 15 3.1 Global Revenue Prostate Cancer Antigen 3 Test by Players 15 3.1.1 Global Prostate Cancer Antigen 3 Test Revenue by Players (2019-2024) 15 3.1.2 Global Prostate Cancer Antigen 3 Test Revenue Market Share by Players (2019-2024) 16 3.2 Global Prostate Cancer Antigen 3 Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 17 3.3 Global Key Players of Prostate Cancer Antigen 3 Test, Ranking by Revenue, 2022 VS 2023 VS 2024 18 3.4 Global Prostate Cancer Antigen 3 Test Market Concentration Ratio 19 3.4.1 Global Prostate Cancer Antigen 3 Test Market Concentration Ratio (CR5 and HHI) 19 3.4.2 Global Top 3 and Top 5 Companies by Prostate Cancer Antigen 3 Test Revenue in 2023 20 3.5 Global Key Players of Prostate Cancer Antigen 3 Test Head office and Area Served 21 3.6 Global Key Players of Prostate Cancer Antigen 3 Test, Product 21 4 Prostate Cancer Antigen 3 Test Breakdown Data by Type 22 4.1 Global Prostate Cancer Antigen 3 Test Historic Market Size by Type (2019-2024) 22 4.2 Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Type (2025-2030) 23 5 Prostate Cancer Antigen 3 Test Breakdown Data by Application 24 5.1 Global Prostate Cancer Antigen 3 Test Historic Market Size by Application (2019-2024) 24 5.2 Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Application (2025-2030) 25 6 North America 26 6.1 North America Prostate Cancer Antigen 3 Test Market Size (2019-2030) 26 6.2 North America Prostate Cancer Antigen 3 Test Market Size by Type 26 6.2.1 North America Prostate Cancer Antigen 3 Test Market Size by Type (2019-2024) 26 6.2.2 North America Prostate Cancer Antigen 3 Test Market Size by Type (2025-2030) 27 6.2.3 North America Prostate Cancer Antigen 3 Test Market Share by Type (2019-2030) 27 6.3 North America Prostate Cancer Antigen 3 Test Market Size by Application 28 6.3.1 North America Prostate Cancer Antigen 3 Test Market Size by Application (2019-2024) 28 6.3.2 North America Prostate Cancer Antigen 3 Test Market Size by Application (2025-2030) 28 6.3.3 North America Prostate Cancer Antigen 3 Test Market Share by Application (2019-2030) 29 6.4 North America Prostate Cancer Antigen 3 Test Market Size by Country 29 6.4.1 North America Prostate Cancer Antigen 3 Test Market Size by Country: 2019 VS 2023 VS 2030 29 6.4.2 North America Prostate Cancer Antigen 3 Test Market Size by Country (2019-2024) 30 6.4.3 North America Prostate Cancer Antigen 3 Test Market Share by Country (2025-2030) 30 6.4.4 United States 31 6.4.5 Canada 32 7 Europe 33 7.1 Europe Prostate Cancer Antigen 3 Test Market Size (2019-2030) 33 7.2 Europe Prostate Cancer Antigen 3 Test Market Size by Type 33 7.2.1 Europe Prostate Cancer Antigen 3 Test Market Size by Type (2019-2024) 33 7.2.2 Europe Prostate Cancer Antigen 3 Test Market Size by Type (2025-2030) 34 7.2.3 Europe Prostate Cancer Antigen 3 Test Market Share by Type (2019-2030) 34 7.3 Europe Prostate Cancer Antigen 3 Test Market Size by Application 35 7.3.1 Europe Prostate Cancer Antigen 3 Test Market Size by Application (2019-2024) 35 7.3.2 Europe Prostate Cancer Antigen 3 Test Market Size by Application (2025-2030) 35 7.3.3 Europe Prostate Cancer Antigen 3 Test Market Share by Application (2019-2030) 36 7.4 Europe Prostate Cancer Antigen 3 Test Market Size by Country 36 7.4.1 Europe Prostate Cancer Antigen 3 Test Market Size by Country: 2019 VS 2023 VS 2030 36 7.4.2 Europe Prostate Cancer Antigen 3 Test Market Size by Country (2019-2024) 37 7.4.3 Europe Prostate Cancer Antigen 3 Test Market Size by Country (2025-2030) 37 7.4.4 Germany 39 7.4.5 France 39 7.4.6 U.K. 40 7.4.7 Italy 40 7.4.8 Spain 41 8 China 42 8.1 China Prostate Cancer Antigen 3 Test Market Size (2019-2030) 42 8.2 China Prostate Cancer Antigen 3 Test Market Size by Type 42 8.2.1 China Prostate Cancer Antigen 3 Test Market Size by Type (2019-2024) 42 8.2.2 China Prostate Cancer Antigen 3 Test Market Size by Type (2025-2030) 43 8.2.3 China Prostate Cancer Antigen 3 Test Market Share by Type (2019-2030) 43 8.3 China Prostate Cancer Antigen 3 Test Market Size by Application 44 8.3.1 China Prostate Cancer Antigen 3 Test Market Size by Application (2019-2024) 44 8.3.2 China Prostate Cancer Antigen 3 Test Market Size by Application (2025-2030) 44 8.3.3 China Prostate Cancer Antigen 3 Test Market Share by Application (2019-2030) 45 9 Asia (excluding China) 46 9.1 Asia Prostate Cancer Antigen 3 Test Market Size (2019-2030) 46 9.2 Asia Prostate Cancer Antigen 3 Test Market Size by Type 46 9.2.1 Asia Prostate Cancer Antigen 3 Test Market Size by Type (2019-2024) 46 9.2.2 Asia Prostate Cancer Antigen 3 Test Market Size by Type (2025-2030) 47 9.2.3 Asia Prostate Cancer Antigen 3 Test Market Share by Type (2019-2030) 47 9.3 Asia Prostate Cancer Antigen 3 Test Market Size by Application 48 9.3.1 Asia Prostate Cancer Antigen 3 Test Market Size by Application (2019-2024) 48 9.3.2 Asia Prostate Cancer Antigen 3 Test Market Size by Application (2025-2030) 48 9.3.3 Asia Prostate Cancer Antigen 3 Test Market Share by Application (2019-2030) 49 9.4 Asia Prostate Cancer Antigen 3 Test Market Size by Region 49 9.4.1 Asia Prostate Cancer Antigen 3 Test Market Size by Region: 2019 VS 2023 VS 2030 49 9.4.2 Asia Prostate Cancer Antigen 3 Test Market Size by Region (2019-2024) 50 9.4.3 Asia Prostate Cancer Antigen 3 Test Market Size by Region (2025-2030) 50 9.4.4 Japan 51 9.4.5 South Korea 52 9.4.6 Southeast Asia 52 9.4.7 India 53 10 Middle East, Africa, and Latin America 54 10.1 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size (2019-2030) 54 10.2 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Type 54 10.2.1 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Type (2019-2024) 54 10.2.2 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Type (2025-2030) 55 10.2.3 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Share by Type (2019-2030) 55 10.3 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Application 56 10.3.1 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Application (2019-2024) 56 10.3.2 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Application (2025-2030) 56 10.3.3 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Share by Application (2019-2030) 57 10.4 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Country 57 10.4.1 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Country: 2019 VS 2023 VS 2030 57 10.4.2 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2019-2024) 58 10.4.3 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2025-2030) 58 10.4.4 Brazil 59 10.4.5 Mexico 60 10.4.6 Middle East 60 10.4.7 Africa 61 11 Key Players Profiles 62 11.1 Hologic 62 11.1.1 Hologic Company Details 62 11.1.2 Hologic Business Overview 62 11.1.3 Hologic Prostate Cancer Antigen 3 Test Introduction 63 11.1.4 Hologic Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 63 11.2 Thermo Fisher Scientific 64 11.2.1 Thermo Fisher Scientific Company Details 64 11.2.2 Thermo Fisher Scientific Business Overview 64 11.2.3 Thermo Fisher Scientific Prostate Cancer Antigen 3 Test Introduction 65 11.2.4 Thermo Fisher Scientific Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 65 11.3 MDxHealth 66 11.3.1 MDxHealth Company Details 66 11.3.2 MDxHealth Business Overview 66 11.3.3 MDxHealth Prostate Cancer Antigen 3 Test Introduction 67 11.3.4 MDxHealth Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 67 11.4 Exosome Diagnostics GmbH 67 11.4.1 Exosome Diagnostics GmbH Company Details 67 11.4.2 Exosome Diagnostics GmbH Business Overview 68 11.4.3 Exosome Diagnostics GmbH Prostate Cancer Antigen 3 Test Introduction 68 11.4.4 Exosome Diagnostics GmbH Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 69 11.5 Creative Diagnostics 69 11.5.1 Creative Diagnostics Company Details 69 11.5.2 Creative Diagnostics Business Overview 70 11.5.3 Creative Diagnostics Prostate Cancer Antigen 3 Test Introduction 70 11.5.4 Creative Diagnostics Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 71 11.6 Lytech 71 11.6.1 Lytech Company Details 71 11.6.2 Lytech Business Overview 72 11.6.3 Lytech Prostate Cancer Antigen 3 Test Introduction 72 11.6.4 Lytech Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 73 11.7 YUBO 73 11.7.1 YUBO Company Details 73 11.7.2 YUBO Business Overview 74 11.7.3 YUBO Prostate Cancer Antigen 3 Test Introduction 74 11.7.4 YUBO Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 75 11.8 MicroDiag Biomedicine 76 11.8.1 MicroDiag Biomedicine Company Details 76 11.8.2 MicroDiag Biomedicine Business Overview 76 11.8.3 MicroDiag Biomedicine Prostate Cancer Antigen 3 Test Introduction 77 11.8.4 MicroDiag Biomedicine Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 77 12 Analyst's Viewpoints/Conclusions 78 13 Appendix 79 13.1 Research Methodology 79 13.1.1 Methodology/Research Approach 79 13.1.2 Data Source 82 13.2 Author Details 85 13.3 Disclaimer 86
SummaryThe global Prostate Cancer Antigen 3 Test market size is projected to reach US 93.64 million by 2030, from US$ 51.69 million in 2023, at a CAGR of 9.09% during 2024-2030. Table of Contents1 Report Overview 11.1 Study Scope 1 1.2 Market Analysis by Type 1 1.2.1 Global Prostate Cancer Antigen 3 Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030 1 1.2.2 RT-PCR 2 1.2.3 ELISA Test 3 1.3 Market by Application 3 1.3.1 Global Prostate Cancer Antigen 3 Test Market Share by Application: 2019 VS 2023 VS 2030 4 1.3.2 Hospital 5 1.3.3 Diagnosis Center 5 1.3.4 Others 5 1.4 Assumptions and Limitations 5 1.5 Study Objectives 6 1.6 Years Considered 7 2 Global Growth Trends 8 2.1 Global Prostate Cancer Antigen 3 Test Market Perspective (2019-2030) 8 2.2 Global Prostate Cancer Antigen 3 Test Growth Trends by Region 9 2.2.1 Global Prostate Cancer Antigen 3 Test Market Size by Region: 2019 VS 2023 VS 2030 10 2.2.2 Prostate Cancer Antigen 3 Test Historic Market Size by Region (2019-2024) 11 2.2.3 Prostate Cancer Antigen 3 Test Forecasted Market Size by Region (2025-2030) 12 2.3 Prostate Cancer Antigen 3 Test Market Dynamics 13 2.3.1 Prostate Cancer Antigen 3 Test Industry Trends 13 2.3.2 Prostate Cancer Antigen 3 Test Market Drivers 13 2.3.3 Prostate Cancer Antigen 3 Test Market Challenges 14 2.3.4 Prostate Cancer Antigen 3 Test Market Restraints 14 3 Competition Landscape by Key Players 15 3.1 Global Revenue Prostate Cancer Antigen 3 Test by Players 15 3.1.1 Global Prostate Cancer Antigen 3 Test Revenue by Players (2019-2024) 15 3.1.2 Global Prostate Cancer Antigen 3 Test Revenue Market Share by Players (2019-2024) 16 3.2 Global Prostate Cancer Antigen 3 Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 17 3.3 Global Key Players of Prostate Cancer Antigen 3 Test, Ranking by Revenue, 2022 VS 2023 VS 2024 18 3.4 Global Prostate Cancer Antigen 3 Test Market Concentration Ratio 19 3.4.1 Global Prostate Cancer Antigen 3 Test Market Concentration Ratio (CR5 and HHI) 19 3.4.2 Global Top 3 and Top 5 Companies by Prostate Cancer Antigen 3 Test Revenue in 2023 20 3.5 Global Key Players of Prostate Cancer Antigen 3 Test Head office and Area Served 21 3.6 Global Key Players of Prostate Cancer Antigen 3 Test, Product 21 4 Prostate Cancer Antigen 3 Test Breakdown Data by Type 22 4.1 Global Prostate Cancer Antigen 3 Test Historic Market Size by Type (2019-2024) 22 4.2 Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Type (2025-2030) 23 5 Prostate Cancer Antigen 3 Test Breakdown Data by Application 24 5.1 Global Prostate Cancer Antigen 3 Test Historic Market Size by Application (2019-2024) 24 5.2 Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Application (2025-2030) 25 6 North America 26 6.1 North America Prostate Cancer Antigen 3 Test Market Size (2019-2030) 26 6.2 North America Prostate Cancer Antigen 3 Test Market Size by Type 26 6.2.1 North America Prostate Cancer Antigen 3 Test Market Size by Type (2019-2024) 26 6.2.2 North America Prostate Cancer Antigen 3 Test Market Size by Type (2025-2030) 27 6.2.3 North America Prostate Cancer Antigen 3 Test Market Share by Type (2019-2030) 27 6.3 North America Prostate Cancer Antigen 3 Test Market Size by Application 28 6.3.1 North America Prostate Cancer Antigen 3 Test Market Size by Application (2019-2024) 28 6.3.2 North America Prostate Cancer Antigen 3 Test Market Size by Application (2025-2030) 28 6.3.3 North America Prostate Cancer Antigen 3 Test Market Share by Application (2019-2030) 29 6.4 North America Prostate Cancer Antigen 3 Test Market Size by Country 29 6.4.1 North America Prostate Cancer Antigen 3 Test Market Size by Country: 2019 VS 2023 VS 2030 29 6.4.2 North America Prostate Cancer Antigen 3 Test Market Size by Country (2019-2024) 30 6.4.3 North America Prostate Cancer Antigen 3 Test Market Share by Country (2025-2030) 30 6.4.4 United States 31 6.4.5 Canada 32 7 Europe 33 7.1 Europe Prostate Cancer Antigen 3 Test Market Size (2019-2030) 33 7.2 Europe Prostate Cancer Antigen 3 Test Market Size by Type 33 7.2.1 Europe Prostate Cancer Antigen 3 Test Market Size by Type (2019-2024) 33 7.2.2 Europe Prostate Cancer Antigen 3 Test Market Size by Type (2025-2030) 34 7.2.3 Europe Prostate Cancer Antigen 3 Test Market Share by Type (2019-2030) 34 7.3 Europe Prostate Cancer Antigen 3 Test Market Size by Application 35 7.3.1 Europe Prostate Cancer Antigen 3 Test Market Size by Application (2019-2024) 35 7.3.2 Europe Prostate Cancer Antigen 3 Test Market Size by Application (2025-2030) 35 7.3.3 Europe Prostate Cancer Antigen 3 Test Market Share by Application (2019-2030) 36 7.4 Europe Prostate Cancer Antigen 3 Test Market Size by Country 36 7.4.1 Europe Prostate Cancer Antigen 3 Test Market Size by Country: 2019 VS 2023 VS 2030 36 7.4.2 Europe Prostate Cancer Antigen 3 Test Market Size by Country (2019-2024) 37 7.4.3 Europe Prostate Cancer Antigen 3 Test Market Size by Country (2025-2030) 37 7.4.4 Germany 39 7.4.5 France 39 7.4.6 U.K. 40 7.4.7 Italy 40 7.4.8 Spain 41 8 China 42 8.1 China Prostate Cancer Antigen 3 Test Market Size (2019-2030) 42 8.2 China Prostate Cancer Antigen 3 Test Market Size by Type 42 8.2.1 China Prostate Cancer Antigen 3 Test Market Size by Type (2019-2024) 42 8.2.2 China Prostate Cancer Antigen 3 Test Market Size by Type (2025-2030) 43 8.2.3 China Prostate Cancer Antigen 3 Test Market Share by Type (2019-2030) 43 8.3 China Prostate Cancer Antigen 3 Test Market Size by Application 44 8.3.1 China Prostate Cancer Antigen 3 Test Market Size by Application (2019-2024) 44 8.3.2 China Prostate Cancer Antigen 3 Test Market Size by Application (2025-2030) 44 8.3.3 China Prostate Cancer Antigen 3 Test Market Share by Application (2019-2030) 45 9 Asia (excluding China) 46 9.1 Asia Prostate Cancer Antigen 3 Test Market Size (2019-2030) 46 9.2 Asia Prostate Cancer Antigen 3 Test Market Size by Type 46 9.2.1 Asia Prostate Cancer Antigen 3 Test Market Size by Type (2019-2024) 46 9.2.2 Asia Prostate Cancer Antigen 3 Test Market Size by Type (2025-2030) 47 9.2.3 Asia Prostate Cancer Antigen 3 Test Market Share by Type (2019-2030) 47 9.3 Asia Prostate Cancer Antigen 3 Test Market Size by Application 48 9.3.1 Asia Prostate Cancer Antigen 3 Test Market Size by Application (2019-2024) 48 9.3.2 Asia Prostate Cancer Antigen 3 Test Market Size by Application (2025-2030) 48 9.3.3 Asia Prostate Cancer Antigen 3 Test Market Share by Application (2019-2030) 49 9.4 Asia Prostate Cancer Antigen 3 Test Market Size by Region 49 9.4.1 Asia Prostate Cancer Antigen 3 Test Market Size by Region: 2019 VS 2023 VS 2030 49 9.4.2 Asia Prostate Cancer Antigen 3 Test Market Size by Region (2019-2024) 50 9.4.3 Asia Prostate Cancer Antigen 3 Test Market Size by Region (2025-2030) 50 9.4.4 Japan 51 9.4.5 South Korea 52 9.4.6 Southeast Asia 52 9.4.7 India 53 10 Middle East, Africa, and Latin America 54 10.1 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size (2019-2030) 54 10.2 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Type 54 10.2.1 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Type (2019-2024) 54 10.2.2 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Type (2025-2030) 55 10.2.3 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Share by Type (2019-2030) 55 10.3 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Application 56 10.3.1 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Application (2019-2024) 56 10.3.2 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Application (2025-2030) 56 10.3.3 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Share by Application (2019-2030) 57 10.4 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Country 57 10.4.1 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Country: 2019 VS 2023 VS 2030 57 10.4.2 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2019-2024) 58 10.4.3 Middle East, Africa, and Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2025-2030) 58 10.4.4 Brazil 59 10.4.5 Mexico 60 10.4.6 Middle East 60 10.4.7 Africa 61 11 Key Players Profiles 62 11.1 Hologic 62 11.1.1 Hologic Company Details 62 11.1.2 Hologic Business Overview 62 11.1.3 Hologic Prostate Cancer Antigen 3 Test Introduction 63 11.1.4 Hologic Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 63 11.2 Thermo Fisher Scientific 64 11.2.1 Thermo Fisher Scientific Company Details 64 11.2.2 Thermo Fisher Scientific Business Overview 64 11.2.3 Thermo Fisher Scientific Prostate Cancer Antigen 3 Test Introduction 65 11.2.4 Thermo Fisher Scientific Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 65 11.3 MDxHealth 66 11.3.1 MDxHealth Company Details 66 11.3.2 MDxHealth Business Overview 66 11.3.3 MDxHealth Prostate Cancer Antigen 3 Test Introduction 67 11.3.4 MDxHealth Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 67 11.4 Exosome Diagnostics GmbH 67 11.4.1 Exosome Diagnostics GmbH Company Details 67 11.4.2 Exosome Diagnostics GmbH Business Overview 68 11.4.3 Exosome Diagnostics GmbH Prostate Cancer Antigen 3 Test Introduction 68 11.4.4 Exosome Diagnostics GmbH Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 69 11.5 Creative Diagnostics 69 11.5.1 Creative Diagnostics Company Details 69 11.5.2 Creative Diagnostics Business Overview 70 11.5.3 Creative Diagnostics Prostate Cancer Antigen 3 Test Introduction 70 11.5.4 Creative Diagnostics Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 71 11.6 Lytech 71 11.6.1 Lytech Company Details 71 11.6.2 Lytech Business Overview 72 11.6.3 Lytech Prostate Cancer Antigen 3 Test Introduction 72 11.6.4 Lytech Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 73 11.7 YUBO 73 11.7.1 YUBO Company Details 73 11.7.2 YUBO Business Overview 74 11.7.3 YUBO Prostate Cancer Antigen 3 Test Introduction 74 11.7.4 YUBO Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 75 11.8 MicroDiag Biomedicine 76 11.8.1 MicroDiag Biomedicine Company Details 76 11.8.2 MicroDiag Biomedicine Business Overview 76 11.8.3 MicroDiag Biomedicine Prostate Cancer Antigen 3 Test Introduction 77 11.8.4 MicroDiag Biomedicine Revenue in Prostate Cancer Antigen 3 Test Business (2019-2024) 77 12 Analyst's Viewpoints/Conclusions 78 13 Appendix 79 13.1 Research Methodology 79 13.1.1 Methodology/Research Approach 79 13.1.2 Data Source 82 13.2 Author Details 85 13.3 Disclaimer 86
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポートQYResearch 社の最新刊レポート本レポートと同じKEY WORD(cancer)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/05 10:26 153.43 円 167.28 円 201.52 円 |